# A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection

> **NCT02836470** · PHASE2 · COMPLETED · sponsor: **Palisade Bio** · enrollment: 112 (actual)

## Conditions studied

- Ileus
- Post-Operative Adhesions

## Interventions

- **DRUG:** LB1148
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02836470
- **Lead sponsor:** Palisade Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2023-09-06
- **Final completion:** 2023-09-08
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836470, "A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02836470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*